Small Molecules as Alternate Substrates for 3‐Methylglutaconylation
The leucine catabolism pathway intermediate, <i>trans</i>-3-methylglutaconyl (3MGC) CoA, is susceptible to a series of non-enzymatic reactions that generate organic acid waste products and protein 3MGCylation. These reactions proceed when inborn errors of metabolism (IEM) in <i>HMGCL</i> or <i>AUH</i> lead to enzyme deficiencies. When <i>trans</i>-3MGC-CoA levels rise, a portion of this metabolite pool isomerizes to <i>cis</i>-3MGC-CoA, forming a diastereomer that is capable of spontaneous intramolecular cyclization, yielding 3MGC anhydride and free CoA. 3MGC anhydride can undergo hydrolysis to 3MGC acid or react with protein lysine residues to 3MGCylate proteins. The present study was designed to examine the ability of small molecules to react with 3MGC anhydride. An antibody directed against 3MGC was employed in vitro experiments designed to assess the ability of candidate biomolecules to attenuate the immunoblot signal intensity of 3MGCylated bovine serum albumin (BSA). When <i>trans</i>-3MGC-CoA was incubated in the presence of glycine, glucosamine, ethanolamine, or glutathione, each of these free amino group-containing molecules, but not N-acetylglucosamine or choline, induced a concentration-dependent decrease in 3MGCylated BSA immunoblot signal intensity. It is concluded that 3MGC anhydride can react with primary amine-containing metabolites to acylate them.
Authors
- Irina Romenskaia
- Robert O. Ryan (ORCID: https://orcid.org/0000-0002-6739-5903)
- Elizabeth A. Jennings (ORCID: https://orcid.org/0000-0002-8277-9171)
Institutions
- University of Nevada, Reno (US)
Publication Details
- Journal
- JIMD Reports
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1002/jmd2.70047
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of General Medical Sciences